Attitudes and Factors Associated With COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
Open Access
- 1 August 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 7 (8), 1242-1244
- https://doi.org/10.1001/jamaoncol.2021.1962
Abstract
The COVID-19 pandemic has had a substantial effect on cancer care.1 The recent widespread availability of vaccines against SARS-CoV-2 is a promising strategy to prevent COVID-19–associated mortality. However, previous reports have shown a high hesitancy rate to receive a COVID-19 vaccine among oncologic patients.2,3 Because breast cancer is the most commonly diagnosed malignant neoplasm,4 it is imperative to evaluate the specific concerns regarding COVID-19 vaccination among patients with this disease.This publication has 5 references indexed in Scilit:
- Acceptance of SARS-CoV-2 vaccination among French patients with cancer: a cross-sectional surveyAnnals Of Oncology, 2021
- A global survey of potential acceptance of a COVID-19 vaccineNature Medicine, 2021
- Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative StudyJCO Global Oncology, 2020
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesCA: A Cancer Journal for Clinicians, 2018